ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

RFA For Patient Compliance Study

September 26, 1980

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NCI “Rescues” 31 Grants From Other Institutes, Funds Them at 41.6 Million; Scores Were 148-270

August 9, 1974

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981